Ronald Weinstein, MD, a pioneer in the development of telemedicine who most recently served as the co-founder and director of the Arizona Telemedicine Program at the UArizona, died Dec. 3 in Tucson.

University of Arizona Health Sciences students and faculty are working to figure out how to reach vaccine-hesitant individuals and communicate more effectively.

"A toast to celebrate the COVID vaccine is fine. But in general, too much alcohol can impact our immune system," said Dr. Natasha Bhuyan, MD, a a clinical assistant professor of Family, Community and Preventive Medicine at the College of Medicine – Phoenix.

Researchers from the UArizona College of Medicine – Tucson found that the bacterial lysate OM-85 blocked SARS-CoV-2 infection by decreasing the ability of the coronavirus to bind to the lung cell surface receptor ACE2.

Lydia Jennings couldn't celebrate her new PhD in 2020 because of the pandemic, so a few months later, she dedicated a 50-mile run to 50 Indigenous scientists, captured in a new film.

The University of Arizona College of Nursing will bring a new master’s nursing program next fall to Gilbert’s University Building and rent more space in the building to accommodate it. The Gilbert Town Council unanimously approved a new lease agreement with UA as part of the consent agenda at its meeting Dec. 14 with a five-year term and an option for five more years thereafter.

Researchers at the University of Arizona Health Sciences are closer to developing a safe and effective non-opioid pain reliever after a study showed that a new compound they created reduces the sensation of pain by regulating a biological channel linked to pain.

A team of researchers at University of Arizona Health Sciences developed a novel nanotechnology that could be used to enhance the fight against colorectal cancer and melanoma. Their approach involved a nanotherapeutic platform that can switch tumors from "immune-cold" to "immune-hot," which stimulated a stronger immune response.

Pfizer and Merk have COVID-19 treatment pills the FDA is considering. Deepta Bhattacharya, PhD, a professor of immunology with the College of Medicine – Tucson, says it appears Pfizer’s treatment is much more effective.